Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases

Overview

Journal Mol Cells

Publisher Elsevier

Specialties Cell Biology
Molecular Biology

Date 2014 May 23

PMID 24850149

Citations 52

Authors

Alexander J S Choi

Stefan W Ryter

Affiliations

Soon will be listed here.

Abstract

Inflammasomes are specialized signaling platforms critical for the regulation of innate immune and inflammatory responses. Various NLR family members (i.e., NLRP1, NLRP3, and IPAF) as well as the PYHIN family member AIM2 can form inflammasome complexes. These multi-protein complexes activate inflammatory caspases (i.e., caspase-1) which in turn catalyze the maturation of select pro-inflammatory cytokines, including interleukin (IL)-1β and IL-18. Activation of the NLRP3 inflammasome typically requires two initiating signals. Toll-like receptor (TLR) and NOD-like receptor (NLR) agonists activate the transcription of pro-inflammatory cytokine genes through an NF-κB-dependent priming signal. Following exposure to extracellular ATP, stimulation of the P2X purinoreceptor-7 (P2X7R), which results in K(+) efflux, is required as a second signal for NLRP3 inflammasome formation. Alternative models for NLRP3 activation involve lysosomal destabilization and phagocytic NADPH oxidase and/or mitochondria-dependent reactive oxygen species (ROS) production. In this review we examine regulatory mechanisms that activate the NLRP3 inflammasome pathway. Furthermore, we discuss the potential roles of NLRP3 in metabolic and cognitive diseases, including obesity, type 2 diabetes mellitus, Alzheimer's disease, and major depressive disorder. Novel therapeutics involving inflammasome activation may result in possible clinical applications in the near future.

Citing Articles

Positive Effect of 6-Gingerol on Functional Plasticity of Microglia in a rat Model of LPS-induced Depression.

Liu C, Zhao Y, Zhao W J Neuroimmune Pharmacol. 2024; 19(1):20.

PMID: 38758335 DOI: 10.1007/s11481-024-10123-z.

Crocin attenuates the lipopolysaccharide-induced neuroinflammation via expression of AIM2 and NLRP1 inflammasome in an experimental model of Parkinson's disease.

Alizadehmoghaddam S, Pourabdolhossein F, Najafzadehvarzi H, Sarbishegi M, Saleki K, Nouri H Heliyon. 2024; 10(3):e25523.

PMID: 38356604 PMC: 10864986. DOI: 10.1016/j.heliyon.2024.e25523.

Association of Denture Use and Chewing Ability with Cognitive Function Analysed Using Panel Data from Korea Longitudinal Study of Aging (2006-2018).

Jun N, Kim J, Jang J Healthcare (Basel). 2023; 11(18).

PMID: 37761702 PMC: 10531446. DOI: 10.3390/healthcare11182505.

Extracellular tau stimulates phagocytosis of living neurons by activated microglia via Toll-like 4 receptor-NLRP3 inflammasome-caspase-1 signalling axis.

Pampuscenko K, Morkuniene R, Krasauskas L, Smirnovas V, Brown G, Borutaite V Sci Rep. 2023; 13(1):10813.

PMID: 37402829 PMC: 10319744. DOI: 10.1038/s41598-023-37887-3.

Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction.

Xu L, Hao L, Yu J, Cheng S, Li F, Ding S Heliyon. 2023; 9(5):e16195.

PMID: 37234646 PMC: 10208821. DOI: 10.1016/j.heliyon.2023.e16195.

References

Skeldon A, Faraj M, Saleh M . Caspases and inflammasomes in metabolic inflammation. Immunol Cell Biol. 2014; 92(4):304-13. DOI: 10.1038/icb.2014.5. View

Glass C, Saijo K, Winner B, Marchetto M, Gage F . Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140(6):918-34. PMC: 2873093. DOI: 10.1016/j.cell.2010.02.016. View

Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J . Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2009; 11(2):136-40. DOI: 10.1038/ni.1831. View

Guarda G, Zenger M, Yazdi A, Schroder K, Ferrero I, Menu P . Differential expression of NLRP3 among hematopoietic cells. J Immunol. 2011; 186(4):2529-34. DOI: 10.4049/jimmunol.1002720. View

Menu P, Vince J . The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol. 2011; 166(1):1-15. PMC: 3193914. DOI: 10.1111/j.1365-2249.2011.04440.x. View

Kessler R, Berglund P, Demler O, Jin R, Koretz D, Merikangas K . The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289(23):3095-105. DOI: 10.1001/jama.289.23.3095. View

Hook V, Kindy M, Hook G . Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem. 2008; 283(12):7745-53. DOI: 10.1074/jbc.M708362200. View

Raison C, Miller A . Malaise, melancholia and madness: the evolutionary legacy of an inflammatory bias. Brain Behav Immun. 2013; 31:1-8. PMC: 3678371. DOI: 10.1016/j.bbi.2013.04.009. View

Pelegrin P, Surprenant A . Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem. 2006; 282(4):2386-94. DOI: 10.1074/jbc.M610351200. View

10.

Fujihara M, Muroi M, Tanamoto K, Suzuki T, Azuma H, Ikeda H . Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol Ther. 2003; 100(2):171-94. DOI: 10.1016/j.pharmthera.2003.08.003. View

11.

Chatterjee S, Rana R, Corbett J, Kadiiska M, Goldstein J, Mason R . P2X7 receptor-NADPH oxidase axis mediates protein radical formation and Kupffer cell activation in carbon tetrachloride-mediated steatohepatitis in obese mice. Free Radic Biol Med. 2012; 52(9):1666-79. PMC: 3341527. DOI: 10.1016/j.freeradbiomed.2012.02.010. View

12.

Feve B, Bastard J . The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009; 5(6):305-11. DOI: 10.1038/nrendo.2009.62. View

13.

Masters S, Dunne A, Subramanian S, Hull R, Tannahill G, Sharp F . Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010; 11(10):897-904. PMC: 3103663. DOI: 10.1038/ni.1935. View

14.

van Diepen J, Stienstra R, Vroegrijk I, van den Berg S, Salvatori D, Hooiveld G . Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion. J Lipid Res. 2012; 54(2):448-56. PMC: 3588871. DOI: 10.1194/jlr.M031963. View

15.

Hornung V, Bauernfeind F, Halle A, Samstad E, Kono H, Rock K . Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9(8):847-56. PMC: 2834784. DOI: 10.1038/ni.1631. View

16.

Saijo K, Winner B, Carson C, Collier J, Boyer L, Rosenfeld M . A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 2009; 137(1):47-59. PMC: 2754279. DOI: 10.1016/j.cell.2009.01.038. View

17.

Finucane M, Stevens G, Cowan M, Danaei G, Lin J, Paciorek C . National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011; 377(9765):557-67. PMC: 4472365. DOI: 10.1016/S0140-6736(10)62037-5. View

18.

Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J . Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440(7081):237-41. DOI: 10.1038/nature04516. View

19.

Lu M, Sun X, Qiao C, Liu Y, Ding J, Hu G . Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation. Neurobiol Aging. 2013; 35(2):421-30. DOI: 10.1016/j.neurobiolaging.2013.08.015. View

20.

Schroder K, Tschopp J . The inflammasomes. Cell. 2010; 140(6):821-32. DOI: 10.1016/j.cell.2010.01.040. View